ABSTRACT:
Background: Premature birth continues to be a major factor in perinatal illness and death worldwide. Inflammatory markers such as C-reactive protein (CRP) have been proposed as predictive biomarkers for preterm birth, yet their predictive utility remains inconclusive. This study aimed to assess the relationship between maternal serum CRP levels evaluated in advance before 22 weeks of gestation and the happenings of spontaneous preterm delivery. Methods: A prospective study conducted at Central Women’s Hospital, Yangon period between January to December in 2016. A total of 253 pregnant women with singleton pregnancies of less than 22 weeks’ gestation were recruited. Maternal serum CRP was measured at enrollment. Women were followed up until delivery. Exclusion criteria included previous preterm delivery, pre-existing medical conditions, obstetric complications, and later development of systemic infection. Final analysis was conducted on 234 participants. Statistical analysis included chi-square and Fisher's exact test, with significance set at p < 0.05. Results: The overall preterm delivery rate was found to be 3.4% (n = 8). CRP levels > 4 mg/L were observed in 75% of those who delivered preterm. However, when analyzed using a cut-off value of > 6 mg/L, the association between elevated CRP and preterm delivery did not reach statistical significance (p = 0.087).
Conclusion: High level of maternal serum CRP levels in early pregnancy not evidenced significant association with spontaneous preterm delivery in this cohort. CRP may not serve as a reliable standalone biomarker for predicting preterm birth, underscoring the need for further large-scale studies incorporating multiple markers.
Cite this article:
Ei Mon Mon Kyaw, Cherry San. Association between maternal serum C-reactive protein in early pregnancy and spontaneous preterm delivery: a prospective hospital based study in Yangon, Myanmar. Research Journal of Pharmacy and Technology. 2025;18(10):4999-2. doi: 10.52711/0974-360X.2025.00722
Cite(Electronic):
Ei Mon Mon Kyaw, Cherry San. Association between maternal serum C-reactive protein in early pregnancy and spontaneous preterm delivery: a prospective hospital based study in Yangon, Myanmar. Research Journal of Pharmacy and Technology. 2025;18(10):4999-2. doi: 10.52711/0974-360X.2025.00722 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-10-61
REFERENCE:
1. World Health Organization. Born too soon: the global action report on preterm birth. In Born too soon: the global action report on preterm birth 2012.
2. Bergh Ella V. Maternal serum markers and prediction of preterm birth. BJOG. 2011; 118(1): 104–6. 10.1111/j.1471-0528.2010.02751
3. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008; 371(9606): 75–84. 10.1016/S0140-6736(08)60074-4
4. Lockwood CJ, Kuczynski E. Markers of risk for preterm birth. Journal of Perinatal Medicine. 1999; 27: 5–20.
5. Goldenberg RL, Hauth JC, Andrews WW. Mechanisms of disease – intrauterine infection and preterm birth. New England Journal of Med. 2000; 342: 1500– 1507.
6. Pepys MB. The acute phase response and C-reactive protein. In: Oxford Textbook of Medicine, 4th Ed. Warrell DA, Cox TM, Firth JD, Benz EJ (Eds). Oxford University Press, Oxford. 2003: 150-156.
7. Mazor M, Hershkowitz R, Ghezzi F, Cohen J, Chaim W, Wiznitzer A. Prolactin concentrations in preterm and term pregnancy and labor. Arch Gynecol Obstet. 1996; 258: 69-74.
8. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, Bollmann R, Duerler R, Mueller MD. Elevated maternal C-reactive protein at the time of preterm labor as a predictor of adverse neonatal outcome. Am J Obstet Gynecol. 2002; 185(5): 1065–70. 10.1067/mob.2002.127660.
9. Lohsoonthorn V, Qiu C, Williams MA. Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clin Biochem. 2007; 40(5–6): 330–5. 10.1016/j.clinbiochem.2006.10.003.
10. Kyaw EM, San C. Association Between Maternal Serum C - reactive protein in Early Pregnancy and Spontaneous Preterm Delivery: A Prospective Hospital-Based Study in Yangon, Myanmar. 10.1016/j.ejogrb.2010.01.017.
11. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine. 1992 Sep 1; 4(5): 361-8.
12. Bastek JA, Elovitz MA. The role and challenges of biomarkers in spontaneous preterm birth and pre- eclampsia. Fertil Steril. 2012; 99: 1117–23.
13. Ozer KT, Kavak ZN, GÃkaslan H, Elter K, Pekin T. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery. European Journal of Obstet Gynecol Reprod Biol. 2005; 122(2): 187.
14. Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-reactive protein: a serological marker for preterm delivery? Acta Obstetricia Et Gynecologica Scandinavica. 2002 Jan 1; 81(5):424-